70 related articles for article (PubMed ID: 26901385)
1. Does SOD3 R213G Homozygosity Influence Morbidity, Mortality, and Lung Function in the General Population?
Kobylecki CJ; Afzal S; Nordestgaard BG
Antioxid Redox Signal; 2016 May; 24(15):884-91. PubMed ID: 26901385
[TBL] [Abstract][Full Text] [Related]
2. Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations.
Dahl M; Bowler RP; Juul K; Crapo JD; Levy S; Nordestgaard BG
Am J Respir Crit Care Med; 2008 Nov; 178(9):906-12. PubMed ID: 18703790
[TBL] [Abstract][Full Text] [Related]
3. Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease.
Juul K; Tybjaerg-Hansen A; Marklund S; Lange P; Nordestgaard BG
Am J Respir Crit Care Med; 2006 Apr; 173(8):858-64. PubMed ID: 16399992
[TBL] [Abstract][Full Text] [Related]
4. Genetically reduced antioxidative protection and increased ischemic heart disease risk: The Copenhagen City Heart Study.
Juul K; Tybjaerg-Hansen A; Marklund S; Heegaard NH; Steffensen R; Sillesen H; Jensen G; Nordestgaard BG
Circulation; 2004 Jan; 109(1):59-65. PubMed ID: 14662715
[TBL] [Abstract][Full Text] [Related]
5. Genetically Low Antioxidant Protection and Risk of Cardiovascular Disease and Heart Failure in Diabetic Subjects.
Kobylecki CJ; Afzal S; Nordestgaard BG
EBioMedicine; 2015 Dec; 2(12):2010-5. PubMed ID: 26844281
[TBL] [Abstract][Full Text] [Related]
6. Superoxide Dismutase 3 R213G Single-Nucleotide Polymorphism Blocks Murine Bleomycin-Induced Fibrosis and Promotes Resolution of Inflammation.
Mouradian GC; Gaurav R; Pugliese S; El Kasmi K; Hartman B; Hernandez-Lagunas L; Stenmark KR; Bowler RP; Nozik-Grayck E
Am J Respir Cell Mol Biol; 2017 Mar; 56(3):362-371. PubMed ID: 27805412
[TBL] [Abstract][Full Text] [Related]
7. Superoxide dismutases, lung function and bronchial responsiveness in a general population.
Siedlinski M; van Diemen CC; Postma DS; Vonk JM; Boezen HM
Eur Respir J; 2009 May; 33(5):986-92. PubMed ID: 19213780
[TBL] [Abstract][Full Text] [Related]
8. A common polymorphism in extracellular superoxide dismutase affects cardiopulmonary disease risk by altering protein distribution.
Hartney JM; Stidham T; Goldstrohm DA; Oberley-Deegan RE; Weaver MR; Valnickova-Hansen Z; Scavenius C; Benninger RK; Leahy KF; Johnson R; Gally F; Kosmider B; Zimmermann AK; Enghild JJ; Nozik-Grayck E; Bowler RP
Circ Cardiovasc Genet; 2014 Oct; 7(5):659-66. PubMed ID: 25085920
[TBL] [Abstract][Full Text] [Related]
9. SOD3 Variant, R213G, Altered SOD3 Function, Leading to ROS-Mediated Inflammation and Damage in Multiple Organs of Premature Aging Mice.
Kwon MJ; Lee KY; Lee HW; Kim JH; Kim TY
Antioxid Redox Signal; 2015 Oct; 23(12):985-99. PubMed ID: 25927599
[TBL] [Abstract][Full Text] [Related]
10. Redistribution of Extracellular Superoxide Dismutase Causes Neonatal Pulmonary Vascular Remodeling and PH but Protects Against Experimental Bronchopulmonary Dysplasia.
Sherlock LG; Trumpie A; Hernandez-Lagunas L; McKenna S; Fisher S; Bowler R; Wright CJ; Delaney C; Nozik-Grayck E
Antioxidants (Basel); 2018 Mar; 7(3):. PubMed ID: 29538340
[TBL] [Abstract][Full Text] [Related]
11. R213G polymorphism in SOD3 protects against bleomycin-induced inflammation and attenuates induction of proinflammatory pathways.
Garcia AM; Allawzi A; Tatman P; Hernandez-Lagunas L; Swain K; Mouradian G; Bowler R; Karimpour-Fard A; Sucharov CC; Nozik-Grayck E
Physiol Genomics; 2018 Sep; 50(9):807-816. PubMed ID: 30004839
[TBL] [Abstract][Full Text] [Related]
12. Vascular effects of the human extracellular superoxide dismutase R213G variant.
Chu Y; Alwahdani A; Iida S; Lund DD; Faraci FM; Heistad DD
Circulation; 2005 Aug; 112(7):1047-53. PubMed ID: 16087794
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA regulation postbleomycin due to the R213G extracellular superoxide dismutase variant is predicted to suppress inflammatory and immune pathways.
Ohlstrom D; Hernandez-Lagunas L; Garcia AM; Allawzi A; Karimpour-Fard A; Sucharov CC; Nozik-Grayck E
Physiol Genomics; 2020 Jun; 52(6):245-254. PubMed ID: 32421439
[TBL] [Abstract][Full Text] [Related]
14. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study.
Thomsen M; Nordestgaard BG; Vestbo J; Lange P
Lancet Respir Med; 2013 Sep; 1(7):543-50. PubMed ID: 24461615
[TBL] [Abstract][Full Text] [Related]
16. Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes.
Mohammedi K; Bellili-Muñoz N; Marklund SL; Driss F; Le Nagard H; Patente TA; Fumeron F; Roussel R; Hadjadj S; Marre M; Velho G
Cardiovasc Diabetol; 2015 Jan; 14():845. PubMed ID: 25855220
[TBL] [Abstract][Full Text] [Related]
17. CHRNA3 and CYP3A5*3 genotype, lung function and chronic obstructive pulmonary disease in the general population.
Kaur-Knudsen D; Bojesen SE; Nordestgaard BG
Pharmacogenet Genomics; 2014 Apr; 24(4):220-9. PubMed ID: 24535486
[TBL] [Abstract][Full Text] [Related]
18. The R213G polymorphism in SOD3 protects against allergic airway inflammation.
Gaurav R; Varasteh JT; Weaver MR; Jacobson SR; Hernandez-Lagunas L; Liu Q; Nozik-Grayck E; Chu HW; Alam R; Nordestgaard BG; Kobylecki CJ; Afzal S; Chupp GL; Bowler RP
JCI Insight; 2017 Sep; 2(17):. PubMed ID: 28878123
[TBL] [Abstract][Full Text] [Related]
19. Redistribution of EC-SOD resolves bleomycin-induced inflammation
Allawzi A; McDermott I; Delaney C; Nguyen K; Banimostafa L; Trumpie A; Hernandez-Lagunas L; Riemondy K; Gillen A; Hesselberth J; Kasmi KE; Sucharov CC; Janssen WJ; Stenmark K; Bowler R; Nozik-Grayck E
FASEB J; 2019 Dec; 33(12):13465-13475. PubMed ID: 31560857
[TBL] [Abstract][Full Text] [Related]
20. Release of extracellular superoxide dismutase into alveolar fluid protects against acute lung injury and inflammation in
Sul C; Lewis C; Dee N; Burns N; Oshima K; Schmidt E; Vohwinkel C; Nozik E
Am J Physiol Lung Cell Mol Physiol; 2023 Apr; 324(4):L445-L455. PubMed ID: 36749572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
